EOC Pharma Group Partners with China National Accord Medicines for Distribution Rights
China-based EOC Pharma Group has announced a strategic partnership with compatriot firm China National Accord...
Deals
Ubrigene Secures RMB 150 Million in Series C+ Financing to Expand Global CGT CDMO Platform
Yiming Cell Biotechnology Co., Ltd, known as Ubrigene Biosciences Inc., a leading gene and cell...
Shanghai Huikai Medical Technology Secures Series A+ Funding for Prostate Stent System
Shanghai Huikai Medical Technology Co., Ltd, a China-based urology device manufacturer, has reportedly raised tens...
RemeGen Ltd Partners with Shandong Cancer Hospital for ADC Development and Integrated System
RemeGen Ltd (HKG: 9995) has announced a strategic partnership with Shandong Cancer Hospital to establish...
Nona Biosciences Partners with Dr. Michael S. Diamond for Viral Disease Monoclonal Antibody Research
Nona Biosciences, a wholly owned subsidiary of Harbour BioMed (HKG: 2142), which operates in the...
Everest Medicines and SPH Keyuan Ink MoU to Expand Xerava Distribution in China
China-based Everest Medicines (HKG: 1952) has announced a Memorandum of Understanding (MoU) with a subsidiary...
China Resources Biopharmaceutical Partners with Hefei Institute and Afana Bio for Joint Lab
China Resources Biopharmaceutical Co., Ltd has announced a strategic partnership with the Hefei Comprehensive National...
Hainan’s Boao Lecheng Partners with Sonova to Advance Hearing Health Solutions in China
The Boao Lecheng Medical Tourism Pilot Zone of Hainan Province has struck a strategic partnership...
Nanjing Chamlion Laser Technology Secures RMB 236 Million in Series B Financing for Dental 3D Printing
Nanjing Chamlion Laser Technology Co., Ltd, a leading provider of dental metal 3D printing solutions...
PackGene Secures Series C Financing to Boost AAV Innovation and Global Expansion
China-based PackGene Biotech has announced the successful completion of a Series C financing round, securing...
Bioworkshops Secures RMB 100 Million in Series A Financing for Biologic Drug Development
Bioworkshops, a Contract Development and Manufacturing Organization (CDMO) based in Suzhou and specializing in biologic...
Shenzhen Core Medical Technology Secures RMB 200 Million in Series C+ Financing for Artificial Heart Tech
Shenzhen Core Medical Technology Co., Ltd, a leading Chinese manufacturer of artificial hearts, has reportedly...
Zephyrm Bioscience Secures Over RMB 200 Million in Series B Financing for Stem-Cell Drug Development
Zephyrm Bioscience, a prominent stem cell drug developer headquartered in Suzhou, has reportedly secured more...
Legend Biotech and Janssen Partner with Novartis on Carvykti Manufacturing and Clinical Supply
Legend Biotech Corporation (NASDAQ: LEGN), a China-based biotech firm, and its US partner Janssen Pharmaceutical...
Jiangxi Jemincare Group Secures Exclusive Rights to Promote MabPharm’s Biosimilar CMAB007
Jiangxi Jemincare Group, a China-based healthcare company, has entered into a licensing agreement with fellow...
Zhejiang Dian Diagnostics Partners with Meituan for Digital Healthcare Services Expansion
Zhejiang Dian Diagnostics Co., Ltd (SHE: 300244), a prominent medical diagnostics company based in China,...
Pfizer and Sinopharm Expand Partnership to Enhance Drug Distribution and Lifecycle Solutions
US pharmaceutical giant Pfizer Inc. (NYSE: PFE) has announced a strategic partnership with China-based Sinopharm...
Shanghai’s PharmaLegacy Files for IPO on STAR, Targets Pre-clinical R&D Expansion
PharmaLegacy Laboratories (Shanghai) Co., Ltd., a Shanghai-based pre-clinical Contract Research Organization (CRO), has reportedly filed...
VintaBio Secures $64M Funding to Revolutionize Viral Vectors for Cell and Gene Therapy
New biotech VintaBio, founded in Philadelphia, Pennsylvania (United States), announces the appointment of CEO David...
Alebund Pharmaceuticals Secures $29M in Pre-Series C Funding and $116M Loan for R&D and Manufacturing
Shanghai-based Alebund Pharmaceuticals has announced the completion of a pre-Series C financing round worth RMB...